Conditions

The ACR board of directors met in Washington, D.C. May 13–15. The trip began with the board and staff participating in Congressional Insight, a computer-simulation exercise that allows participants to experience some of the pressures and rewards of being a U.S. representative.

Annual Meeting Opportunities for Pediatric Rheumatologists

Staff | July 1, 2009

The ACR/ARHP Annual Scientific Meeting is the premier event for specialists in the field of rheumatology, and this year’s planning committee is committed to providing attendees with educational opportunities specifically tailored to their areas of interest.

Diagnosis: Myopathy

Edward C. Smith, MD, and Dwight D. Koeberl, MD, PhD | July 1, 2009

Presentation and evaluation of metabolic causes

From Paper to Practice

Gretchen Henkel | June 1, 2009

Using ACR RA recommendations to improve quality of care

Vasculitis

Gary S. Hoffman, MD | June 1, 2009

A New perspective on when and how it begins

PQRI Now Includes RA Measures Group

Salahuddin Kazi, MD, Melesia Tillman, CPC, CCP, and Amy S. Miller | May 1, 2009

In 2008, the only Physician Quality Reporting Initiative (PQRI) measure that applied to rheumatoid arthritis (RA) was disease-modifying antirheumatic drug therapy. For 2009, five new RA measures were included, for a total of six measures in the new RA Measures Group. The five new measures were developed in 2008 by the National Committee for Quality Assurance in collaboration with the ACR and the American Medical Association’s Physician Consortium for Performance Improvement and were subsequently adopted by Medicare.